Autres langues Artivion, Inc.

Actions

AORT

US2289031005

Equipement, fournitures et distribution médicale

Marché Fermé - NYSE Autres places de cotation 22:00:03 24/07/2026			Varia. 5j.	Varia. 1 janv.
25,28 ^USD	+1,12%		+0,88%	-44,57%

29/06	Artivion obtient l'homologation de la FDA pour sa prothèse hybride ; le titre grimpe en avant-bourse	MT
29/06	Artivion reçoit l'approbation de la FDA pour sa prothèse hybride AMDS	CI

Autres langues

23/07	Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell 2000 Defensive Index
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell Microcap Value Benchmark Index
29/06	Artivion's Hybrid Prosthesis Device Gets FDA Premarket Approval; Shares Up Pre-Bell
29/06	Artivion Receives Fda Approval for Amds Hybrid Prosthesis
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell 2000 Value Benchmark
29/06	Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell 3000E Index
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell Microcap Index
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell 3000E Growth Benchmark
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell 3000E Value Benchmark
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell Microcap Growth Benchmark Index
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell 3000 Value Benchmark
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell 2000 Value-Defensive Index
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell 2000 Growth-Defensive Index
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell Small Cap Comp Value Benchmark
29/06	Artivion, Inc.(NYSE:AORT) dropped from Russell 2500 Value Benchmark
15/06	Artivion Insider Sold Shares Worth $910,739, According to a Recent SEC Filing
10/06	Artivion to Participate in the 2026 Truist Securities MedTech Conference
18/05	Artivion Closes $175 Million Acquisition of Endospan
18/05	Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System
18/05	Artivion Completes Acquisition of Endospan Ltd.
18/05	Artivion, Inc. completed the acquisition of Endospan Ltd.
07/05	Artivion: Q1 Earnings Snapshot
07/05	Earnings Flash (AORT) Artivion, Inc. Reports Q1 Revenue $116.3M, vs. FactSet Est of $115.7M